Here is the latest update from Cardiff Council, covering: River Taff at Forest Farm Maintenance Works; Cardiff's COVID-19 case and test numbers; and vaccination totals for Cardiff and Vale of Glamorgan.

River Taff at Forest Farm Maintenance Works

Essential maintenance work conducted by Natural Resources Wales (NRW), is due to take place next to the River Taff at Forest Farm, from Wednesday 10 November.

The work includes removing hawthorn growing alongside the flood wall next to Forest Farm Road to make sure it remains stable.

NRW will also clear the embankment to keep it relatively free of vegetation so it can be easily inspected for any damage.

The vegetation is also cleared to allow grass to grow on the embankment. Grass creates a strong and consistent root network, making the banks more resilient.

The footpath running alongside Forest Farm Road near the rugby club and sports field will be closed, but the road itself will remain open for cars to use and for people to continue using the Taff trail.

Future works include essential safety work to trees. All trees, that can be retained in this woodland will be retained, both living and dead, as they provide very important habitat for a wide variety of species.

The work is expected to be completed by Wednesday, 17^thNovember.

Cardiff Cases and Tests - 7 Days Data (29 October - 04 November)

Based on latest figures from Public Health Wales

Data correct as of:

08 November 2021, 09:00

Cases: 2,179

Cases per 100,000 population: 593.9 (Wales: 527.7 cases per 100,000 population)

Testing episodes: 9,570

Testing per 100,000 population: 2,608.3

Positive proportion: 22.8% (Wales: 20.5% positive proportion)

Cardiff & Vale University Health Board Vaccination Status Update - 09 November

Data provided by CAVUHB

Based on the figures available at the time of publication.

Please note that there may be minor amendments to data as it is validated over time.

The total number of vaccination doses given by the Cardiff & Vale University Health Board so far, in both local authority areas:  841,332 (1^stDose: 395,438 2^ndDose: 359,855 3^rdDose: 5,490 Boosters: 78,310)

Cohort Data - Last updated: 01 November

• 80 and over: 20,321 / 94.6% (1^stDose) 20,133 / 93.8% (2^ndDose)
• 75-79: 14,997 / 96.4% (1^stDose) 14,838 / 95.4% (2^ndDose)
• 70-74: 21,410 / 95.8% (1^stDose) 21,277 / 95.2% (2^ndDose)
• 65-69: 21,978 / 94.3% (1^stDose) 21,732 / 93.3% (2^ndDose)
• 60-64: 26,081 / 92.4% (1^stDose) 25,756 / 91.3% (2^ndDose)
• 55-59: 29,440 / 90.4% (1^stDose) 28,942 / 88.8% (2^ndDose)
• 50-54: 29,117 / 88.1% (1^stDose) 28,484 / 86.2% (2^ndDose)
• 40-49: 55,646 / 82% (1^stDose) 53,799 / 79.3% (2^ndDose)
• 30-39: 61,330 / 76.1% (1^stDose) 57,569 / 71.5% (2^ndDose)
• 18-29: 81,552 / 77.3% (1^stDose) 73,189 / 69.5% (2^ndDose)
• 16-17: 4,057 / 74.2% (1^stDose) 324 / 5.9% (2^ndDose)
• 12-15: 12,829 / 48.2% (1^stDose)

• Care home residents: 2,119 / 98.2% (1^stDose) 2,094 / 97.1% (2^ndDose)
• Clinically extremely vulnerable: 11,252 / 94.5% (1^stDose) 11,055 / 92.8% (2^ndDose)
• Underlying Health Conditions: 45,948 / 90.3% (1^stDose) 44,408 / 87.2% (2^ndDose)
• Underlying Health Conditions (12-15): 573 / 58.2% (1^stDose)